Nano Agriculture
Market Cap
₹370 ₹370 Cr.
P/E
19.73
PEG
0.57
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

Thesis lives on converting vast spare biodiesel capacity into dispatched litres to OMCs, with only modest help from higher realisation and glycerin residual

Bull path requires early Jhajjar and Kanpur commissioning plus stronger industrial and glycerin offtake lifting both volume and realisation

Bear path is OMC tender stagnation and poor LOI conversion combined with feedstock cost pressure that stalls volume and compresses spreads

Key Ratios

Debt to Equity
Debt to Equity
0.36
Div Yield (%)
Div Yield (%)
1.41
Individual < 2 lac
Individual < 2 lac
13.06 %
Institutions
Institutions
0.10 %
Market cap
Market cap
370 Cr
No. of Shareholders
No. of Shareholders
10,803
OPM (%)
OPM (%)
18.12 %
PE
PE
19.73
Prom Holding
Prom Holding
57.34 %
ROCE (%)
ROCE (%)
17.34
ROE (%)
ROE (%)
10.39
Sales
Sales
257 Cr
  • Kotyark Industries
  • Harrisons Malayalam
  • Sheetal Universal
Last updated on 28 Sep 2026
  • Kotyark Industries makes biodiesel (B100) for fuel and blending, with crude glycerin as a by-product, selling mainly to oil-marketing companies and to bulk industrial and retail buyers.
  • It runs 4,80,000 KLPA of biodiesel and ~63,000 KLPA of glycerin capacity at about 7–8% blended utilisation. The plants process ~10–15 feedstocks, mostly used cooking oil. Glycerin serves pharma, food and personal-care uses.
  • Since FY23 management has shifted toward oil-marketing allocations for better margins. A 2023 merger with Yamuna Bio Energy, a biodiesel business, added Gujarat capacity.
  • Consolidated profit depends on subsidiary Kotyark Bio Specialities, which earned ₹3.40Cr of ₹4.46Cr in Q1FY27. Bulk and retail buyers rose to 30% of FY26 revenue.
  • Q1FY27 revenue grew 11.5%, trailing the guided pace. Standalone margin fell to 8.43% on a fossil-biofuel price gap. The subsidiary held consolidated margin at 12.74%.
  • Working capital absorbs accounting profit. FY26 operating cash flow was −₹3.9Cr despite reported profit. New plants are to be funded from internal accruals.
  • Near-term earnings depend on converting the ₹173.45Cr oil-marketing allocation into dispatches. Management guides 15–20% revenue and utilisation growth for FY27, toward 60–70% utilisation medium term.
  • It is building 200 KLPD biodiesel plants at Jhajjar and Kanpur. Management aspires to 25–30% revenue CAGR and 18–22% EBITDA margin over three years.
  • Four vegetable-ester storage tanks at the Sirohi plant remain seized and criminal proceedings against a director continue. Management says there is no production loss.
  • Oil-marketing allocation execution 92 days from Aug 2026 to early Nov, plus a 2-month extension
    the ₹173.45Cr allocation becomes revenue only as the companies raise indents and purchase orders.
  • First quarter under the oil-marketing allocation Oct–Nov 2026
    Q2FY27 results show whether utilisation lifts and standalone margin recovers.
  • Export licensing ~Oct 2026–Feb 2027
    approval opens export revenue, which management expects in FY27.
  • New Jhajjar and Kanpur biodiesel plants Dec 2026
    each adds 200 KLPD of capacity against the 4,80,000 KLPA installed base, funded from internal accruals.
  • Sirohi plant legal matter No stated timeline
    a court or Bio-Fuel Authority outcome would decide release or write-down of the seized tanks.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
17
52W Range
High
46
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Kotyark Industries Ltd. Business

Kotyark Industries Limited focuses on manufacturing biofuel as an eco-friendly alternative to traditional fossil fuels, contributing to renewable green energy and sustainable development by reducing greenhouse gas emissions.

Kotyark Industries major competitors are Harrisons Malayalam, SC Agrotech, Nath Bio-Genes (I), Tierra Agrotech, Sheetal Universal, Mangalam Seeds, Indo US Bio-Tech.
Market Cap of Kotyark Industries is ₹321 Crs.
While the median market cap of its peers are ₹266 Crs.

Kotyark Industries seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation May Sep Mar Sep Mar Sep Dec Dec
Conference Call Jun
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material